TADALAFIL-RZ, TADALAFIL-DRLA, TADALAFIL-DR.REDDY'S, TADALAFIL-REDDY'S (Dr Reddy's Laboratories (Australia) Pty Ltd)
Product name
TADALAFIL-RZ, TADALAFIL-DRLA, TADALAFIL-DR.REDDY'S, TADALAFIL-REDDY'S
Date registered
Evaluation commenced
Decision date
Approval time
202 working days (255)
Active ingredients
tadalafil
Registration type
New generic medicine
Indication
TADALAFIL-RZ, TADALAFIL-DRLA, TADALAFIL-DR.REDDY'S, TADALAFIL-REDDY'S (tablets) is indicated for the treatment of:
- Erectile dysfunction (ED) in adult males;
- Moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males.
Tadalafil 10 mg and 20 mg film-coated tablets are indicated for the treatment of:
- Erectile dysfunction (ED) in adult males.